Atenolol, methyldopa, and chlorthalidone in moderate hypertension
- PMID: 12850
- PMCID: PMC1604043
- DOI: 10.1136/bmj.1.6053.76
Atenolol, methyldopa, and chlorthalidone in moderate hypertension
Abstract
Combined treatment with low doses of different drugs is widely used for moderate hypertension. The effects of atenolol and methyldopa at two dose levels and in combination at the lower doses were studied in patients with moderate hypertension on continuous treatment with moderate hypertension on continuous treatment with chlorthalidone. The mean reduction in standing blood pressures obtained with atenolol 150 and 300 mg/day was about 27/17 mm Hg and with methyldopa 750 and 1500 mg/day about 28/14 mm Hg. Combined treatment with atenolol 150 mg/day and methyldopa 750 mg/day for four weeks resulted in a reduction of 38/25 mm Hg. No difference was observed between the two doses of methyldopa. The lower dose of atenolol was better than the lower dose of methyldopa in reducing lying and standing diastolic blood pressures. These findings show that in patients on continuous treatment with chlorthalidone the addition of atenolol alone or methyldopa alone or of atenolol and methyldopa in combination is effective in the treatment of moderate hypertension.
Similar articles
-
Atenolol and methyldopa in the treatment of hypertension.Postgrad Med J. 1977;53 Suppl 3:123-7. Postgrad Med J. 1977. PMID: 337266 Clinical Trial. No abstract available.
-
Atenolol and chlorthalidone in combination for hypertension.Br J Clin Pharmacol. 1979 Apr;7(4):357-63. doi: 10.1111/j.1365-2125.1979.tb00946.x. Br J Clin Pharmacol. 1979. PMID: 375958 Free PMC article. Clinical Trial.
-
Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.Drugs Exp Clin Res. 1985;11(12):851-60. Drugs Exp Clin Res. 1985. PMID: 2873012
-
[Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].Presse Med. 1992 Nov 7;21(37):1762-7. Presse Med. 1992. PMID: 1362612 Review. French.
-
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].Kardiologiia. 2005;45(12):99-102. Kardiologiia. 2005. PMID: 16353055 Review. Russian. No abstract available.
Cited by
-
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.Br Med J (Clin Res Ed). 1984 Jan 14;288(6411):106-11. doi: 10.1136/bmj.288.6411.106. Br Med J (Clin Res Ed). 1984. PMID: 6419809 Free PMC article. Clinical Trial.
-
Atenolol in the treatment of pregnancy-induced hypertension.Br J Clin Pharmacol. 1981 Nov;12(5):725-30. doi: 10.1111/j.1365-2125.1981.tb01296.x. Br J Clin Pharmacol. 1981. PMID: 7332738 Free PMC article.
-
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001. Drugs. 1979. PMID: 38096 Review.
-
Allopathy--the therapeutic legacy.Ir J Med Sci. 1989 Jan;158(1):4-9. doi: 10.1007/BF02942007. Ir J Med Sci. 1989. PMID: 2661491 Review. No abstract available.
-
Atenolol and metoprolol in mild hypertension.Br Med J. 1978 Nov 4;2(6147):1269. doi: 10.1136/bmj.2.6147.1269. Br Med J. 1978. PMID: 361165 Free PMC article. Clinical Trial. No abstract available.
References
-
- Lancet. 1976 Mar 6;1(7958):503-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources